{"id":1576,"date":"2020-12-06T12:02:59","date_gmt":"2020-12-06T12:02:59","guid":{"rendered":"https:\/\/medxelerator.com\/?p=1576"},"modified":"2020-12-06T12:03:00","modified_gmt":"2020-12-06T12:03:00","slug":"medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack","status":"publish","type":"post","link":"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/","title":{"rendered":"MEDX Xelerator Approves New \u201cX Lab\u201d Project to Improve Treatment of Peripheral Venous Disease Care, Forms VeinWay Under CEO Jordan Pollack"},"content":{"rendered":"\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"160\" height=\"62\" src=\"https:\/\/medxelerator.com\/wp-content\/uploads\/2019\/02\/logo.png\" alt=\"\" class=\"wp-image-1005\"\/><\/figure><\/div>\n\n\n\n<p class=\"has-text-align-center\"><em>VeinWay Receives Grant from The Ideation (Tnufa) Incentive Program of The Israel Innovation Authority for $35K<\/em><\/p>\n\n\n\n<p>OR YEHUDA, Israel \u2013 December 3, 2020 &#8212; <a href=\"https:\/\/medxelerator.com\/\">MEDX Xelerator<\/a>, an Israel-based medical device and digital health incubator, today announced the approval of its latest \u201cX Lab\u201d project focused on treating peripheral venous disease (PVD). The newly formed company, VeinWay, will be headed by experienced biomedical engineer and freshman entrepreneur Jordan Pollack.&nbsp;<\/p>\n\n\n\n<p>VeinWay recently received a grant of over $35K from The Ideation (Tnufa) Incentive Program of The Israel Innovation Authority. The goal of the grant is to support the company in reaching proof of concept and business feasibility.<\/p>\n\n\n\n<p>MEDX Xelerator\u2019s X Lab program was established to cultivate promising innovation at its earliest stage, supporting and helping inventors and entrepreneurs cultivate their ideas addressing complex unmet clinical needs. By providing resources, industry expertise and wide-spread networking capabilities, MEDX supports its X Lab entrepreneurs in developing a proof-of-concept, and then, if a proof of concept is demonstrated, advancing these early stage startups to enter the formal incubator program.<\/p>\n\n\n\n<p>\u201cIt\u2019s a great privilege to be inducted into the X Lab program and gain the full support and guidance of the extended MEDX team,\u201d said Jordan Pollack, X Lab Entrepreneur in Residence and CEO of VeinWay. \u201cI am excited to collaborate with MEDX\u2019s experienced and well-connected leadership to leverage my peripheral vasculature expertise and together, to provide the industry with much-needed innovation to improve care for patients with PVD.\u201d<\/p>\n\n\n\n<p>Pollack has spent his career building his engineering experience within the medical device field, having held multiple positions in established, globally traded companies including Boston Scientific and InspireMD. Pollack was also the President and CEO of his own startup, LiveSAVR Solutions, which developed a novel smart guidewire for accurate placement of transcatheter aortic valves. Pollack holds master\u2019s and bachelor\u2019s degrees in biomedical engineering from the University of Michigan.<\/p>\n\n\n\n<p>\u201cOur relationship with Jordan stems back to a joint project with Boston Scientific, where we first noticed his extensive knowledge of the peripheral venous industry and entrepreneurial spirit,\u201d said Shai Policker, CEO of MEDX Xelerator. \u201cFollowing his recent immigration to Israel, we are delighted to play a role in guiding and nurturing his growth and development within this field, and are happy to assist in Jordan\u2019s goal of elevating the standard of care for PVD management.\u201d<\/p>\n\n\n\n<p class=\"has-text-align-center\">###<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><strong>About MEDX Xelerator<\/strong><\/p>\n\n\n\n<p>MEDX Xelerator is a leading MedTech incubator formed as an initiative of MEDX Ventures Group together with Boston Scientific, Intellectual Ventures\u2019 Invention Science Fund and Sheba Medical Center. Operating under the auspices of the Israel Innovation Authority, MEDX leverages the healthcare expertise and industry experience of its team with the industry leading insights of its partners to nurture its portfolio companies into successful medical ventures for the benefit of patients and health care professionals. MEDX\u2019s current portfolio companies includes: <a href=\"https:\/\/www.endoways.com\/\">EndoWays<\/a>, <a href=\"https:\/\/www.appendmedical.com\/\">Append Medical<\/a>, <a href=\"https:\/\/www.exeromedical.com\/\">Exero<\/a><a href=\"https:\/\/www.exeromedical.com\/\"> Medical<\/a>, and PatenSee, Swift Duct and Dimoveo. <strong><\/strong><\/p>\n\n\n\n<p>For more information, visit <a href=\"https:\/\/medxelerator.com\/\">https:\/\/medxelerator.com\/<\/a>.&nbsp;<\/p>\n\n\n\n<p>Follow MEDX on&nbsp;<a href=\"https:\/\/www.linkedin.com\/company\/medx-xelerator-lp\/?trk=top_nav_home\">LinkedIn<\/a>.<\/p>\n\n\n\n<p><strong>Media Contact<br><\/strong>Nicole Grubner for MEDX Xelerator<br><a href=\"mailto:nicole.grubner@finnpartners.com\">nicole.grubner@finnpartners.com<\/a><br>+1-929-222-8011<\/p>\n","protected":false},"excerpt":{"rendered":"<p>VeinWay Receives Grant from The Ideation (Tnufa) Incentive Program of The Israel Innovation Authority for $35K OR YEHUDA, Israel \u2013 December 3, 2020 &#8212; MEDX Xelerator, an Israel-based medical device and digital health incubator, today announced the approval of its latest \u201cX Lab\u201d project focused on treating peripheral venous disease (PVD). The newly formed company, [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MEDX Xelerator Approves New \u201cX Lab\u201d Project to Improve Treatment of Peripheral Venous Disease Care, Forms VeinWay Under CEO Jordan Pollack - MEDX Xelerator<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MEDX Xelerator Approves New \u201cX Lab\u201d Project to Improve Treatment of Peripheral Venous Disease Care, Forms VeinWay Under CEO Jordan Pollack - MEDX Xelerator\" \/>\n<meta property=\"og:description\" content=\"VeinWay Receives Grant from The Ideation (Tnufa) Incentive Program of The Israel Innovation Authority for $35K OR YEHUDA, Israel \u2013 December 3, 2020 &#8212; MEDX Xelerator, an Israel-based medical device and digital health incubator, today announced the approval of its latest \u201cX Lab\u201d project focused on treating peripheral venous disease (PVD). The newly formed company, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/\" \/>\n<meta property=\"og:site_name\" content=\"MEDX Xelerator\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-06T12:02:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-12-06T12:03:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medxelerator.com\/wp-content\/uploads\/2019\/02\/logo.png\" \/>\n<meta name=\"author\" content=\"Soli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Soli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/\"},\"author\":{\"name\":\"Soli\",\"@id\":\"https:\/\/medxelerator.com\/#\/schema\/person\/6aa968b04aab58d62b5cdf4743a360de\"},\"headline\":\"MEDX Xelerator Approves New \u201cX Lab\u201d Project to Improve Treatment of Peripheral Venous Disease Care, Forms VeinWay Under CEO Jordan Pollack\",\"datePublished\":\"2020-12-06T12:02:59+00:00\",\"dateModified\":\"2020-12-06T12:03:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/\"},\"wordCount\":532,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/medxelerator.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/medxelerator.com\/wp-content\/uploads\/2019\/02\/logo.png\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/\",\"url\":\"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/\",\"name\":\"MEDX Xelerator Approves New \u201cX Lab\u201d Project to Improve Treatment of Peripheral Venous Disease Care, Forms VeinWay Under CEO Jordan Pollack - MEDX Xelerator\",\"isPartOf\":{\"@id\":\"https:\/\/medxelerator.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/medxelerator.com\/wp-content\/uploads\/2019\/02\/logo.png\",\"datePublished\":\"2020-12-06T12:02:59+00:00\",\"dateModified\":\"2020-12-06T12:03:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#primaryimage\",\"url\":\"https:\/\/medxelerator.com\/wp-content\/uploads\/2019\/02\/logo.png\",\"contentUrl\":\"https:\/\/medxelerator.com\/wp-content\/uploads\/2019\/02\/logo.png\",\"width\":160,\"height\":62},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/medxelerator.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MEDX Xelerator Approves New \u201cX Lab\u201d Project to Improve Treatment of Peripheral Venous Disease Care, Forms VeinWay Under CEO Jordan Pollack\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/medxelerator.com\/#website\",\"url\":\"https:\/\/medxelerator.com\/\",\"name\":\"MEDX Xelerator\",\"description\":\"Accelerating Science for Life\",\"publisher\":{\"@id\":\"https:\/\/medxelerator.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/medxelerator.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/medxelerator.com\/#organization\",\"name\":\"MEDX XELERATOR\",\"url\":\"https:\/\/medxelerator.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medxelerator.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/medxelerator.com\/wp-content\/uploads\/2024\/01\/MEDX-LOGO.png\",\"contentUrl\":\"https:\/\/medxelerator.com\/wp-content\/uploads\/2024\/01\/MEDX-LOGO.png\",\"width\":819,\"height\":333,\"caption\":\"MEDX XELERATOR\"},\"image\":{\"@id\":\"https:\/\/medxelerator.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/medxelerator.com\/#\/schema\/person\/6aa968b04aab58d62b5cdf4743a360de\",\"name\":\"Soli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medxelerator.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f43cd27ac4be2a789af3eadaa07c484?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f43cd27ac4be2a789af3eadaa07c484?s=96&d=mm&r=g\",\"caption\":\"Soli\"},\"url\":\"https:\/\/medxelerator.com\/author\/soli-dmedxelerator-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MEDX Xelerator Approves New \u201cX Lab\u201d Project to Improve Treatment of Peripheral Venous Disease Care, Forms VeinWay Under CEO Jordan Pollack - MEDX Xelerator","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/","og_locale":"en_US","og_type":"article","og_title":"MEDX Xelerator Approves New \u201cX Lab\u201d Project to Improve Treatment of Peripheral Venous Disease Care, Forms VeinWay Under CEO Jordan Pollack - MEDX Xelerator","og_description":"VeinWay Receives Grant from The Ideation (Tnufa) Incentive Program of The Israel Innovation Authority for $35K OR YEHUDA, Israel \u2013 December 3, 2020 &#8212; MEDX Xelerator, an Israel-based medical device and digital health incubator, today announced the approval of its latest \u201cX Lab\u201d project focused on treating peripheral venous disease (PVD). The newly formed company, [&hellip;]","og_url":"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/","og_site_name":"MEDX Xelerator","article_published_time":"2020-12-06T12:02:59+00:00","article_modified_time":"2020-12-06T12:03:00+00:00","og_image":[{"url":"https:\/\/medxelerator.com\/wp-content\/uploads\/2019\/02\/logo.png"}],"author":"Soli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Soli","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#article","isPartOf":{"@id":"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/"},"author":{"name":"Soli","@id":"https:\/\/medxelerator.com\/#\/schema\/person\/6aa968b04aab58d62b5cdf4743a360de"},"headline":"MEDX Xelerator Approves New \u201cX Lab\u201d Project to Improve Treatment of Peripheral Venous Disease Care, Forms VeinWay Under CEO Jordan Pollack","datePublished":"2020-12-06T12:02:59+00:00","dateModified":"2020-12-06T12:03:00+00:00","mainEntityOfPage":{"@id":"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/"},"wordCount":532,"commentCount":0,"publisher":{"@id":"https:\/\/medxelerator.com\/#organization"},"image":{"@id":"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#primaryimage"},"thumbnailUrl":"https:\/\/medxelerator.com\/wp-content\/uploads\/2019\/02\/logo.png","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/","url":"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/","name":"MEDX Xelerator Approves New \u201cX Lab\u201d Project to Improve Treatment of Peripheral Venous Disease Care, Forms VeinWay Under CEO Jordan Pollack - MEDX Xelerator","isPartOf":{"@id":"https:\/\/medxelerator.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#primaryimage"},"image":{"@id":"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#primaryimage"},"thumbnailUrl":"https:\/\/medxelerator.com\/wp-content\/uploads\/2019\/02\/logo.png","datePublished":"2020-12-06T12:02:59+00:00","dateModified":"2020-12-06T12:03:00+00:00","breadcrumb":{"@id":"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#primaryimage","url":"https:\/\/medxelerator.com\/wp-content\/uploads\/2019\/02\/logo.png","contentUrl":"https:\/\/medxelerator.com\/wp-content\/uploads\/2019\/02\/logo.png","width":160,"height":62},{"@type":"BreadcrumbList","@id":"https:\/\/medxelerator.com\/medx-xelerator-approves-new-x-lab-project-to-improve-treatment-of-peripheral-venous-disease-care-forms-veinway-under-ceo-jordan-pollack\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medxelerator.com\/"},{"@type":"ListItem","position":2,"name":"MEDX Xelerator Approves New \u201cX Lab\u201d Project to Improve Treatment of Peripheral Venous Disease Care, Forms VeinWay Under CEO Jordan Pollack"}]},{"@type":"WebSite","@id":"https:\/\/medxelerator.com\/#website","url":"https:\/\/medxelerator.com\/","name":"MEDX Xelerator","description":"Accelerating Science for Life","publisher":{"@id":"https:\/\/medxelerator.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medxelerator.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/medxelerator.com\/#organization","name":"MEDX XELERATOR","url":"https:\/\/medxelerator.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medxelerator.com\/#\/schema\/logo\/image\/","url":"https:\/\/medxelerator.com\/wp-content\/uploads\/2024\/01\/MEDX-LOGO.png","contentUrl":"https:\/\/medxelerator.com\/wp-content\/uploads\/2024\/01\/MEDX-LOGO.png","width":819,"height":333,"caption":"MEDX XELERATOR"},"image":{"@id":"https:\/\/medxelerator.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/medxelerator.com\/#\/schema\/person\/6aa968b04aab58d62b5cdf4743a360de","name":"Soli","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medxelerator.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f43cd27ac4be2a789af3eadaa07c484?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f43cd27ac4be2a789af3eadaa07c484?s=96&d=mm&r=g","caption":"Soli"},"url":"https:\/\/medxelerator.com\/author\/soli-dmedxelerator-com\/"}]}},"_links":{"self":[{"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/posts\/1576"}],"collection":[{"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/comments?post=1576"}],"version-history":[{"count":3,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/posts\/1576\/revisions"}],"predecessor-version":[{"id":1579,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/posts\/1576\/revisions\/1579"}],"wp:attachment":[{"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/media?parent=1576"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/categories?post=1576"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/tags?post=1576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}